Drug Envy: Law firms are gearing up for potential FDA approval of generic biologic drugs, Jenna Greene reports. Brand-name biologic drugs constitute a $40 billion industry. Health care legislation under consideration in Congress would create a regulatory pathway for generic versions of the drugs for the first time.
Sued by Everyman: A lawsuit about unused balances on calling cards in the District of Columbia has morphed into a test of D.C. consumer-protection laws, Jordan Weissmann reports. The D.C. Court of Appeals is planning to hear the case en banc, and lawyers for the plaintiffs' bar and for corporate defendants are piling on.
Holder's Amicus Briefs: The Justice Department acknowledged Friday that Attorney General Eric Holder Jr. did not list at least six U.S. Supreme Court briefs that a questionnaire asked him to disclose during his confirmation process in late 2008, David Ingram reports.
And in Inadmissible: Chief Justice John Roberts Jr. recounts his doughnut test, D.C. Court of Appeals clerk Garland Pinkston Jr. discusses his retirement, and a spokeswoman for 9th Circuit nominee Goodwin Liu explains why Liu received his Oxford master's degree in the mail.
Comments